BIIB (BIIB) Stock Price & Analysis
BIIB (BIIB) rose 0.00% to USD 202.19 as of July 25, 2026 at 01:13 UTC, according to Nexqual real-time market data.
BIIB last closed at USD 202.19; the session ranged USD 200.04–203.3 on volume of 565,571 shares. Market capitalization is —, with a 52-week range of USD 124.56–219.72 (NMS). Source: Nexqual, July 25, 2026 at 01:13 UTC.
Key Statistics (as of July 25, 2026 at 01:13 UTC)
| Price | USD 202.19 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 202.19 |
| Open | USD 202.19 |
| Day Range | USD 200.04 – 203.3 |
| 52-Week Range | USD 124.56 – 219.72 |
| Volume | 565,571 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BIIB)
Nexqual's technical model rates BIIB "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 01:13 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 50.47 (neutral) |
| vs SMA50 | Above (USD 199.43) |
| MACD | 0.18 (positive) |
From BIIB's Latest SEC 10-K Filing (filed 2026-02-06)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | USD 656.01 | ▲ 0.74% |
| AMGN | Amgen Inc. | USD 376.04 | ▲ 2.73% |
| GILD | Gilead Sciences, Inc. | USD 129.31 | ▼ 0.79% |
| VRTX | Vertex Pharmaceuticals Incorpor | USD 477.36 | ▲ 1.01% |
| ILMN | Illumina, Inc. | USD 194.09 | ▲ 1.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:13 UTC. This page is informational and not investment advice.